Source:http://linkedlifedata.com/resource/pubmed/id/16872764
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2006-10-23
|
pubmed:abstractText |
Spironolactone is a steroidal diuretic showing incomplete oral behaviour because of its low solubility and slow dissolution rate. In this study, we applied the nanoprecipitation method to prepare spironolactone-loaded nanocapsules, at laboratory-scale and pilot-scale. The effect of several formulation variables on the spironolactone-loaded nanocapsules properties (average size, drug release rate and drug entrapment) was investigated. The optimized formulations at laboratory-scale and pilot-scale lead to the preparation of spironolactone-loaded nanocapsules with a mean size of 320 and 400 nm, respectively, a high encapsulation efficiency (96.21% and 90.56% respectively), both stable for 6 months. The release of spironolactone from nanocapsules was rapid and complete in a simulated gastric fluid, therefore recourse to spironolactone nanoencapsulation should enhance its oral bioavailability and probably its efficiency. The optimized formulations lead to a high drug-concentration in the liquid preparation (1.5 mg/ml) allowing minimizing the preparation volume administered for children medication.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Nanocapsules,
http://linkedlifedata.com/resource/pubmed/chemical/Oils,
http://linkedlifedata.com/resource/pubmed/chemical/Poloxamer,
http://linkedlifedata.com/resource/pubmed/chemical/Polyesters,
http://linkedlifedata.com/resource/pubmed/chemical/Solvents,
http://linkedlifedata.com/resource/pubmed/chemical/Spironolactone,
http://linkedlifedata.com/resource/pubmed/chemical/polycaprolactone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0378-5173
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
325
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
124-31
|
pubmed:dateRevised |
2008-8-14
|
pubmed:meshHeading |
pubmed-meshheading:16872764-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:16872764-Chemistry, Pharmaceutical,
pubmed-meshheading:16872764-Drug Compounding,
pubmed-meshheading:16872764-Drug Stability,
pubmed-meshheading:16872764-Drug Storage,
pubmed-meshheading:16872764-Microscopy, Electron, Transmission,
pubmed-meshheading:16872764-Molecular Weight,
pubmed-meshheading:16872764-Nanocapsules,
pubmed-meshheading:16872764-Nanotechnology,
pubmed-meshheading:16872764-Oils,
pubmed-meshheading:16872764-Particle Size,
pubmed-meshheading:16872764-Poloxamer,
pubmed-meshheading:16872764-Polyesters,
pubmed-meshheading:16872764-Solubility,
pubmed-meshheading:16872764-Solvents,
pubmed-meshheading:16872764-Spironolactone,
pubmed-meshheading:16872764-Time Factors
|
pubmed:year |
2006
|
pubmed:articleTitle |
Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use.
|
pubmed:affiliation |
Laboratoire d'Automatique et de Génie des Procédés (LAGEP), UMR-CNRS 5007, CPE Lyon, Université Claude Bernard Lyon 1, Bât 308 G, 43 Boulevard du 11 Novembre 1918, F-69622 Villeurbanne Cedex, France. limayem@lagep.univ-lyon.fr
|
pubmed:publicationType |
Journal Article
|